USA – Johnson & Johnson has appointed Shawn Millerick as President of Vision Care, Americas, effective November 11, 2024.
In his new role, Millerick will oversee the strategic direction and growth of Johnson & Johnson’s Vision Care portfolio across North America and LATAM, which includes the globally renowned Acuvue contact lens family.
Millerick’s leadership will emphasize accelerating digital transformation to enhance outcomes for both patients and eye care professionals.
Peter Menziuso, Company Group Chairman of Vision at Johnson & Johnson MedTech, expressed his confidence in Millerick’s leadership:
“Shawn’s exceptional expertise and transformative vision will propel our Vision Care business into its next phase of growth.”
With a background in commercial strategy and consumer healthcare, including over-the-counter marketing and shopper insights, Millerick brings a wealth of experience to the role.
On his appointment, Millerick shared: “It’s an honor to return to the vision sector and join a team deeply committed to improving lives. I’m inspired by the mission of Vision Made Possible and look forward to contributing to this journey.”
Leadership expansion in surgical vision
As part of this transition, Erin Powers has been promoted to Vice President of North America for Surgical Vision, where she will lead operations across the region.
Powers and Millerick are expected to collaborate closely to drive growth and create synergies within Johnson & Johnson’s unified Vision organization.
Launch of TECNIS Odyssey: A game-changer in cataract surgery
This announcement coincides with Johnson & Johnson’s expanded U.S. rollout of its groundbreaking TECNIS Odyssey presbyopia-correcting intraocular lens (PC-IOL).
Built on the TECNIS platform, this innovative lens offers patients unparalleled vision across all distances, significantly reducing reliance on glasses.
Key Benefits of TECNIS Odyssey include:
Peter Menziuso praised the TECNIS Odyssey IOL, stating: “Cataract surgery provides a once-in-a-lifetime chance to improve vision. With TECNIS Odyssey, patients can experience sharp, uninterrupted vision at all distances, without the need for glasses.”
Addressing the growing need
Cataracts, which affect 17.2% of Americans over 40, remain a significant concern, with only a fraction of patients undergoing surgery.
Many individuals also face presbyopia, a progressive condition that complicates close focusing.
The TECNIS Odyssey IOL presents an opportunity to address both issues during cataract surgery, offering a comprehensive solution.
Dr. George O. Waring IV, Medical Director of the Waring Vision Institute, hailed TECNIS Odyssey as the most advanced and balanced PC-IOL available, noting:
“This lens sets a new standard in full-range vision, delivering exceptional contrast and minimal visual disturbances. It’s a breakthrough unlike anything we’ve seen before.”
